Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

Arthritis and Rheumatism

Volumn 41, Issue 12, 1998, Pages 2196-2204

  Bresnihan, Barry ^a   Alvaro Gracia, José Maria ^b   Cobby, Mark ^c   Doherty, Michael ^d   Domljan, Zlatko ^e   Emery, Paul ^f   Nuki, George ^g   Pavelka, Karel ^h   Rau, Rolf ⁱ   Rozman, Blaz ^j   Watt, Iain ^k   Williams, Bryan ^l   Aitchison, Roger ^m   McCabe, Dorothy ^m   Musikic, Predrag ^m  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c FRENCHAY HOSPITAL   (United Kingdom)

^d NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^e KBC Zagreb   (Croatia)

^f LEEDS GENERAL INFIRMARY   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

ⁱ Evangelisches Fach krankenhaus Ratingen   (Germany)

^j UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^k BRISTOL ROYAL INFIRMARY   (United Kingdom)

^l UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^m AMGEN INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; FEMALE; HAND; HUMANS; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; JOINTS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; RHEUMATOID FACTOR; SIALOGLYCOPROTEINS;

EID: 17444394445     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2     Document Type: Article

References (15)

1. Harris ED. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
3. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
4. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
5. Chandrasekhar S, Harvey AK, Hrubey PS, Bendele AM. Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol 1990;55:382-94.
6. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor-alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
7. Staite ND, Richard KA, Aspar DG, Franz KA, Galinet LA, Dunn CJ. Induction of acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin. Arthritis Rheum 1990;33:253-60.
8. McDonnell J, Hoerrner LA, Lark MW, Harper C, Dey T, Lobner J, et al. Recombinant human interleukin-1β-induced increase in levels of proteoglycans, stromelysin, and leukocytes in rabbit synovial fluid. Arthritis Rheum 1992;35:799-805.
9. Van Lent PLEM, van den Hoek AEM, van den Bersselaar LAM, van de Loo FAJ, Eykholt HE, Brouwer WFM, et al. Early cartilage degradation in cationic immune complex arthritis in mice: relative role of interleukin-1, the polymorphonuclear cell (PMN) and PMN elastase. J Rheumatol 1994;21:321-9.
10. Van Lent PLEM, van de Loo AAJ, Holthuysen AEM, van den Bersselaar LAM, Vermeer H, van den Berg WB. Major role for interleukin 1 but not tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J Rheumatol 1995;22:2250-8.
11. Van de Loo AAJ, van den Berg WB. Effects of murine recombinant interleukin-1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990;49:238-45.
12. O'Byrne EM, Blancuzzi V, Wilson DE, Wong M, Jeng AY. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 1990;33:1023-8.
13. Van Beuningen HM, Arntz OJ, van den Berg WB. In vivo effects of interleukin-1 on articular cartilage: prolongation of proteoglycan metabolic disturbances in old mice. Arthritis Rheum 1991;34: 606-15.
14. Hutchinson NI, Lark MW, MacNaul KL, Harper C, Hoerrner LA, McDonnell J, et al. In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1β. Arthritis Rheum 1992;35:1227-33.
15. Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB. Role of interleukin-1 tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995;38:164-72.